Alandag Celal
- 17 tahun pengalaman
- Lokasi: Turquia, Sivas
Bandingkan dokter dan harga Imunoterapi teratas di Turquia. Temukan pencocokan terbaik Anda di sini.
Kami akan memilih dokter terbaik berdasarkan kebutuhan dan anggaran Anda.
Ditinjau secara medis oleh Fahad Mawlood
Editor Medis & Data ScientistDokter teratas
2
Turquia
Ulasan
14000+
Dari pasien asli
Bandingkan harga untuk Imunoterapi di negara-negara teratas
Ketuk negara untuk melihat dokter teratas dan harga
Rentang paling populer
$1.5K
$2.25K
$3K
$3.75K
$4.5K
$5.25K
$6K+
$6.75K+
$1,200 – $2,800
Kebanyakan pasien membayar di dalam rentang ini
Biaya pasti tergantung pada dokter yang dipilih, teknik, area yang ditangani, dan kebutuhan Anda secara individu.
Dapatkan penawaran pasti untuk kasus Anda.
Dapatkan rencana perawatan yang dipersonalisasi gratis dan pilih opsi terbaik. Tanpa komitmen · Tidak ada pembayaran untuk layanan kami
Memilih klinik di luar negeri bisa membuat stres. Di Bookimed, dengan 800.000+ pasien telah dibantu, kami memahami kekhawatiran Anda. Kami tahu cara menemukan dokter terpercaya, opsi harga terbaik, dan solusi bahkan untuk kasus yang rumit. Kami siap membimbing Anda di setiap langkah.
Yan Matsiivskiy
Kepala Tim Koordinator Medis
4300++ perjalanan pasien yang dipandu
3 tahun di Bookimed
278 pasien dari Turkey telah menemukan dokternya melalui kami bulan ini
Kuis 2 menit
Ceritakan tujuan, anggaran, dan waktu Anda
Pencocokan Manusia + AI
Algoritme kami menemukan kecocokan, koordinator memverifikasi kesesuaian
Pilihan Anda Siap
Bandingkan harga, paket, tanggal. Chat dengan koordinator Anda
Bingung dengan banyak pilihan?
Membimbing pengobatan Anda
Koordinator pribadi berpengalaman medis






| Peringkat | Dokter | pengalaman | Cocok Untuk | Apa yang Membedakan Mereka | Klinik & Lokasi | Konsultasi |
|---|
Leading Turkish immunotherapy doctors hold advanced medical oncology specializations verified by prestigious European and American boards. These experts frequently complete training at top global institutions like MD Anderson or Oxford University. Most are active members of the European Society for Medical Oncology (ESMO) and maintain research-driven clinical protocols.
Bookimed Expert Insight: Data shows a high concentration of internationally trained talent at Anadolu Medical Center, where specialists like Dr. Zafer Gulbas and Dr. Yesim Yildirim maintain formal affiliations with Johns Hopkins Medicine. These doctors often possess dual certifications from both Turkish and European boards, ensuring treatment protocols mirror latest global standards. Consultation fees for these experts range from $100 to $300, providing access to professors with 25+ years of experience.
Patient Consensus: Patients note that doctors are exceptionally open to new, evidence-based treatments that are not widely available elsewhere. They often mention feeling that their lives are truly valued by highly dedicated oncology teams. Many were impressed by how quickly specialists apply specific, personalized procedures during their journey.
Immunotherapy doctors in Turkey at internationally accredited hospitals typically speak fluent English. Many specialists hold certifications from European or American boards. These experts frequently complete advanced training in the USA, UK, or Germany to master next-generation cancer treatments.
Bookimed Expert Insight: Data shows that immunotherapy specialists in Turkey often have deeper international ties than general physicians. For instance, Dr. Zafer Gulbas at Anadolu Medical Center trained at the Fred Hutchinson Cancer Research Center in the USA and Princess Margaret Hospital in Canada. This global exposure ensures doctors are comfortable discussing complex protocols in English.
Patient Consensus: Patients note that while nurses and technicians might have limited English, their primary oncologists are highly professional and communicative. Many were relieved to find that coordinators manage all logistics and translation needs. This support allows patients to focus entirely on their treatment journey.
Turkish oncologists use the same immunotherapy drugs as those in the US and Germany. Leading centers follow international protocols from ESMO and NCCN. Qualified doctors source authentic medications like Keytruda directly from global manufacturers. Top hospitals maintain academic links with US institutions to match modern treatment standards.
Bookimed Expert Insight: Data suggests Turkish specialists often have direct training at the very institutions where these drugs were developed. For instance, Dr. Zafer Gulbas trained at MD Anderson and Fred Hutchinson in the USA. This ensures the application of immunotherapy drugs follows the exact nuances of US protocols. Patients can find top-tier expertise in Istanbul and Antalya at clinics with JCI and OECI accreditations.
Patient Consensus: Patients note that cancer regimens in major Turkish hospitals match exactly with what US oncologists recommend. They feel reassured seeing familiar brands like Roche and Merck being used. People often mention how professional teams coordinate everything from medication procurement to scheduling without any delays.
Highly rated immunotherapy doctors in Turkey include Professor Zafer Gulbas and Professor Bulent Karagoz. These specialists practice at JCI-accredited centers affiliated with Johns Hopkins Medicine. They hold certifications from the European Society for Medical Oncology. Most completed advanced training at top clinical centers in the USA, Canada, and Israel.
Bookimed Expert Insight: Data shows a concentration of top oncology talent at Anadolu Medical Center. Most specialists there possess international fellowships from renowned institutions like MD Anderson or Oxford. This provides patients with access to global treatment protocols. Consultations with these experts typically start from $100 to $215.
Patient Consensus: Patients are often impressed by the dedication and professionalism of the medical teams. They note that hospitals value human life and provide quick, attentive care. Many find the coordination between translators and hospital staff makes the complex journey much easier.
Turkish oncologists determine immunotherapy eligibility by evaluating tumor biomarkers, cancer histology, and patient performance. Specialists like Dr. Bulent Karagoz and Professor Yesim Yildirim analyze PD-L1 expression, MSI-H/dMMR status, and genomic profiles to verify if immune checkpoint inhibitors will effectively target the specific cancer cells.
Bookimed Expert Insight: Turkish specialists provide a rare advantage through dual expertise in tumor biology and immunology. For instance, Professor Yesim Yildirim and Dr. Bulent Karagoz at Anadolu Medical Center hold extensive research backgrounds in tumor immunology. This allow them to create personalized immunotherapy plans beyond standard protocols, often integrating findings from their 100+ combined scientific publications.
Patient Consensus: Patients note that doctors take a deeply personal approach rather than following rigid rules. They appreciate how multidisciplinary teams, including radiologists and oncologists, review every test result together. Many felt relieved when doctors explained exactly how their specific biomarkers made them a candidate for treatment.